top of page

Artificial Intelligence in Drug Discovery Industry Analytical Framework

Artificial Intelligence has the potential to significantly improve drug discovery and development processes. Artificial intelligence (AI) is being used in drug discovery to speed up the process of identifying potential drug candidates, improve the accuracy of predictions, and reduce the cost of research. AI algorithms are able to analyze large datasets, including chemical and biological data, to identify patterns and potential drug targets. Furthermore, AI can be used to analyze data from clinical trials to identify patient subgroups that are most likely to respond to a particular treatment, which can help researchers design more efficient and effective clinical trials. The current page outlines the analytical framework developed to understand the comprehensive overview of components of AI in the Drug Discovery Industry.

Analytical Framework
AI In Drug Discovery (1).png
Analytical Framework Teaser
Знімок екрана 2023-03-07 о 11.42.18.png
Full Documentation
Знімок екрана 2023-03-07 о 11.42.26.png

Artificial Intelligence in Drug Discovery Analytical Framework

Advanced R&D

Biomarkers Development

Drug Discovery

Focus on Applications of AI for Drug Discovery 

The field of using Artificial Intelligence for drug discovery is a rapidly growing area of research that has the potential to revolutionize the process of drug discovery and development. 

AI-Assisted Diagnostics

At-Home Cancer Detection

Clinical Decision Support

Medical Images Analysis

Patients Outcome Prediction

Personalized Treatment Options 

Focus on Applications of AI for

Oncology Diagnostics and Treatment

There is a growing interest in the applications of AI for oncology diagnostics and treatment as the use of AI has the potential to greatly improve cancer care. AI algorithms can analyze large amounts of patient data, medical images, and treatment history to identify patterns and features that are associated with treatment response and toxicity, and use this information to develop personalized treatment plans for individual patients.

Established Drug Discovery-Oriented Entities

Compounds Classification

Drug

Repurposing

Identifying New Drug Candidates

Identifying New Drug Pathways

Identifying New Drug Structures

Hit Identification

Lead Optimization

Predictive Drug Modeling

Target Identification

Virtual 
Screening

Identifying Drug to Drug Interactions

Identifying New Drug Indications

Identifying New Metabolic Pathways

Identifying Suitable Patients

Imaging Analysis

Patient Stratification

Predictive Modeling

Real-Time Monitoring

Automated End-to-End 
Drug Analysis

Automated End-to-End Production

ADME/PK Modeling

Experiment Data Analyzing

Preclinical Protocol Optimization

Robotic Hands

 High Throughput Screening

Chemical Data  Analyzing

Clinical Trials Data Analyzing

Predictive Patient Reaction Modeling

Virtual Experiment Processing

Drug Safety Improving

Preclinical Trials Prediction

Preclinical Imaging Analysis

Robotic

Laboratories

Collaborative

Robots

Imaging 
Data Analysis

Lab Experiments Data Analyzing

Early Drug Development

Early drug development is the stage of drug development that occurs before preclinical and clinical development. It involves identifying potential drug candidates, conducting initial testing to determine their pharmacological properties, and selecting candidates for further development. This stage has several peculiarities that distinguish it from other stages of drug development.

Clinical Drug Development

Clinical drug development is the stage of drug development that involves testing the safety and efficacy of a drug candidate in humans. This stage is typically divided into three phases, each with its peculiarities.

Data Processing

Data processing is an essential step in drug development as it involves analyzing and interpreting data to identify potential drug candidates and understand their safety and efficacy. 

Preclinical Development and Automation

AI has been increasingly used to support preclinical drug development by modeling the properties and potential outcomes of drug candidates. One way AI can do this is by analyzing the properties of a drug candidate's structure, such as its molecular weight, size, and shape, to predict its activity and efficacy. AI can also analyze genetic variations in specific cellular lines or mice strains to simulate preclinical studies and make predictions about potential efficacy and toxicity.

End-to-End Drug Development

End-to-end drug development is a comprehensive approach to drug development that involves all stages, from discovery to commercialization. The process can be divided into several stages, each of which has its peculiarities

Access Deep Pharma Intelligence Big Data Analytics Dashboard

AI for Drug Discovery Industry Analytical Framework formed the basis of the Deep Pharma Intelligence Big Data Analytics Dashboard, tracking the status of 700 companies, 1,400 investors, 260 collaborations, various clinical trials, publications, news, and a large amount of other valuable information. This delivers advanced market intelligence, interactive mindmaps, benchmarking for companies, investors, and technologies, competitive and SWOT analysis.

image_2022-12-30_152938946.png
DPI Dashboard.gif
bottom of page